Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.

Myeloid Leukemia ◽

Prognostic Models ◽

Intensive Chemotherapy ◽

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome:

Cancer ◽

10.1002/cncr.21723 ◽

2006 ◽

Vol 106 (5) ◽

pp. 1090-1098 ◽

Cited By ~ 404

Author(s):

Hagop Kantarjian ◽

Susan O'Brien ◽

Jorge Cortes ◽

Francis Giles ◽

Stefan Faderl ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-1193 ◽

2007 ◽

Vol 13 (23) ◽

pp. 7107-7112 ◽

Cited By ~ 39

Author(s):

Michael Grövdal ◽

Rasheed Khan ◽

Anni Aggerholm ◽

Petar Antunovic ◽

Jan Astermark ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndromes ◽

Older Patients ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Dna Hypermethylation ◽

Negative Effect ◽

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

Annals of Hematology ◽

10.1007/s00277-004-0889-0 ◽

2004 ◽

Vol 83 (8) ◽

Cited By ~ 37

Author(s):

W.K. Hofmann ◽

G. Heil ◽

C. Zander ◽

S. Wiebe ◽

O.G. Ottmann ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Case Medical Research ◽

10.31525/ct1-nct03940352 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Faculty Opinions recommendation of A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119427.575617 ◽

2008 ◽

Author(s):

Arati Rao

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Low Dose ◽

Randomized Study ◽

Front Line ◽

Line Therapy ◽

Low Dose Cytarabine ◽

A Real Life Turkish Experience Of Venetoclax Treatment In High Risk Myelodysplastic Syndrome And Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.04.004 ◽

2021 ◽

Author(s):

Aliihsan Gemici ◽

Fahir Ozkalemkas ◽

Mehmet Hilmi Dogu ◽

Atakan Tekinalp ◽

Inci Alacacioglu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Real Life ◽

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

Leukemia ◽

10.1038/sj.leu.2402591 ◽

2002 ◽

Vol 16 (9) ◽

pp. 1615-1621 ◽

Cited By ~ 42

Author(s):

M Oosterveld ◽

◽

P Muus ◽

S Suciu ◽

C Koller ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Prognostic Factors ◽

High Risk ◽

Myeloid Leukemia ◽

Secondary Acute Myeloid Leukemia ◽

Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

Leukemia Research ◽

10.1016/j.leukres.2018.10.011 ◽

2018 ◽

Vol 75 ◽

pp. 29-35 ◽

Cited By ~ 4

Author(s):

Pankit Vachhani ◽

Raed Al Yacoub ◽

Austin Miller ◽

Fan Zhang ◽

Tara L. Cronin ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Single Center ◽

Single Center Experience ◽

Outcome of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome According to Health Insurance Status

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2014.03.003 ◽

2014 ◽

Vol 14 (6) ◽

pp. 509-513 ◽

Cited By ~ 2

Author(s):

Ali Al-Ameri ◽

Ankit Anand ◽

Mohamed Abdelfatah ◽

Zeyad Kanaan ◽

Tracy Hammonds ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Health Insurance ◽

High Risk ◽

Myeloid Leukemia ◽

Insurance Status ◽

Health Insurance Status ◽

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Leukemia ◽

10.1038/s41375-018-0312-9 ◽

2018 ◽

Vol 33 (2) ◽

pp. 379-389 ◽

Cited By ~ 145

Author(s):

Jorge E. Cortes ◽

Florian H. Heidel ◽

Andrzej Hellmann ◽

Walter Fiedler ◽

B. Douglas Smith ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Low Dose ◽

Newly Diagnosed ◽

Low Dose Cytarabine ◽